Commentary

Page 5

Recently published articles about Commentary

JCP
rTMS for Treatment-Resistant Depression: Mismatch of Evidence and Insurance Coverage Policies
Commentary

April 26, 2023

The authors argue that insurance companies’ prior authorization process overly restricts access to rTMS, which has proven effectiveness for TRD.
, , , et al
JCP
The Emerging Treatment Landscape in Schizophrenia
Commentary

January 18, 2023

This article provides an overview of emerging therapies poised to transform the treatment paradigm for patients with living with schizophrenia.
,
JCP
Schizophrenia: Salient Symptoms and Pathophysiology
Commentary

January 18, 2023

This article notes the distinction between positive and negative schizophrenic symptoms and provides an updated overview of disease pathophysiology.
JCP
Adverse Events and Treatment Adherence in Schizophrenia
Commentary

January 18, 2023

This article examines the effects of treatment-related adverse events on adherence to medication and strategies to improve adherence in practice.
,
JCP
The Epidemiology and Global Burden of Schizophrenia
Commentary

January 18, 2023

This article explores the costs and burden of schizophrenia and provides an overview of disease prevalence, incidence, and trends over time.
,
JCP
Optimizing Therapy Selection, Sequencing in Schizophrenia
Commentary

January 18, 2023

This article summarizes the current treatment landscape in schizophrenia, along with contexts in which agents should be prescribed.
,
JCP
Defining and Achieving Treatment Recovery in Schizophrenia
Commentary

January 18, 2023

This article defines treatment recovery in schizophrenia and summarizes strategies clinicians can pursue to improve patient outcomes.
,
JCP
Actualizing and Sustaining Recovery-Oriented Care
Commentary

January 16, 2023

Jack Tsai, PhD, comments on intensity of therapy and scalability issues in a recent study of the Opening Doors to Recovery program for SMI.
JCP
Recent Advances in Screening for Mild Cognitive Impairment and Alzheimer Disease
Commentary

December 26, 2022

Among the most transformative Alzheimer disease discoveries is the existence of biomarkers which can manifest decades before onset of disease-related dementia.
,
JCP
The Differential Diagnosis and Treatment of Mild Cognitive Impairment and Alzheimer Disease
Commentary

December 26, 2022

Navigating the associated differential diagnosis in AD is essential as various causes of cognitive impairment require different treatment strategies.
,
JCP
Developing Mental Illness Stigma–Reducing Interventions
Commentary

December 19, 2022

Research on antistigma interventions needs to look at sustained changes in attitudes and knowledge over time.
PCC
An Update on the Future of Wilson Disease Management
Commentary

November 29, 2022

Due to Wilson disease myriad manifestations, its rarity, and its range of symptoms, differential diagnosis may be challenging, leading to delays in treatment. This Neuroscience Commentary reviews diagnostic acumen...

Live Webinar
and Q&A With
Dr Deligiannidis

JULY 16 · REGISTER NOW
Webinar ad featuring Dr. Kristina M. Deligiannidis on PPD treatment options

Subscribe to read
more articles

Subscribe